$LIDR

AEye (LIDR) Q2 2026 Earnings Call Transcript

AEye (LIDR) reported Q2 2026 revenue of $202,000, up ninefold YoY and 100% vs Q1, with first-half revenue of $303,000. It had 25 revenue-generating customers. GAAP net loss was $10.0 million ($0.22/share). Cash and marketable securities were $71.5 million. Management guided full-year cash use of $30M to $35M.

Original reporting
Published Aug 14, 2026, 12:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 12:32 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AEye (LIDR) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$LIDRBullishMed
01

Why it matters

Key trading inputs are the disclosed Q2 financials, the introduction of contract development revenue, and explicit full-year cash-use guidance that implies heavier second-half spending during manufacturing ramp.

02

Market read

Traders can update models for lidar commercialization and cash burn trajectory based on the disclosed revenue acceleration and manufacturing-ramp cash guidance.

03

What to watch

Defense engagement growth and the sports analytics contract are encouraging, but the call highlights longer OEM evaluation periods, which may delay revenue recognition into later quarters.

Relevance 8/10Novelty 7/10Timing: post-call, for positioning ahead of next earnings and any financing/ramp updates

Background

AEye’s Q2 2026 call focuses on commercialization progress for its Apollo lidar platform, including defense activity and new vertical expansion.

Company-level read

Ticker impact

$LIDRBullishMedium confidence
Context

AEye reported Q2 revenue of $202,000, added a new contract development revenue stream, and guided full-year cash use of $30M to $35M.

Expected impact

Near-term bias to the upside on commercialization signals, but expect volatility around the guided cash consumption ramp.

Evidence & confidence

Revenue growth, customer count expansion, and NVIDIA DRIVE AGX Thor validation are incremental positives, while explicit second-half cash outflow guidance can pressure valuation and raise financing-risk concerns.

Market effects

Supports the lidar commercialization narrative, emphasizing software-defined performance and ecosystem validation as gating factors for adoption.

No specific regional demand signal beyond defense and automotive/trucking verticals.

NVIDIA ecosystem interoperability could matter for OEM sensor qualification timelines globally.

Counterpoint

The revenue base remains very small in absolute dollars, so the ramp-driven cash burn could outweigh near-term fundamentals if commercial conversion lags.

Key entities

  • AEye, Inc.

    Lidar company reporting Q2 2026 results and guiding full-year cash use while highlighting commercialization and NVIDIA ecosystem validation.

  • Matthew Fisch

    CEO who discussed software-defined architecture and customer evaluation timelines.

  • Conor Tierney

    CFO who provided cash-use guidance and commentary on second-half consumption.

  • LITEON

    Manufacturing partner supporting a dedicated production line for Apollo units.

  • NVIDIA

    Platform validation mentioned via NVIDIA DRIVE AGX Thor interoperability.

Related articles

$LIDRMed

AEye, Inc. (LIDR): Results of Operations and Financial Condition

AEye, Inc. (LIDR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ea030082701ex99-1.htm PRESS RELEASE DATED AUGUST 6, 2026 Exhibit 99.1 AEye Reports Second Quarter 2026 Results; Commercial Pipeline Again Reaches Record Level Q2 Revenue Approximately Doubled Sequentially and Grew Approximately Nine-Fold Year-Over-Year; First-Half Reven

$PLSEMedAI 8/10

Pulse Biosciences (PLSE) Q2 2026 Earnings Call Transcript

Pulse Biosciences (PLSE) reported Q2 2026 revenue of $434,000 and GAAP net loss of $24.7 million. Cash and equivalents rose to $101.6 million by June 30, 2026 after $57.5 million in ATM proceeds. NANOPULSE-AF enrollment exceeded halfway with early October completion target; CE Mark for the catheter expected in 2H 2026.

$SGHighAI 9/10

Sweetgreen (SG) Q2 2026 Earnings Call Transcript

Sweetgreen (SG) reported Q2 2026 revenue of $192.7M, up 4% YoY, driven by 36 net new restaurant openings. Same-store sales fell 6.2%. Restaurant-level margin was 13.1% and adjusted EBITDA was a $0.2M loss. FY2026 guidance was revised for cyclospora impacts, with comparable sales expected to decline 7% to 8% and restaurant margin 10.5% to 11.0%.

$ASLEMed

AerSale (ASLE) Q2 2026 Earnings Call Transcript

AerSale (ASLE) reported Q2 2026 revenue of $70.9 million, down from $107.4 million, citing fewer flight equipment sales. Adjusted EBITDA was $2.2 million (3.1% margin) versus $18.3 million. Net loss was $5.6 million. Leasing and TechOps rose, while inventory increased to $376 million. Management expects a $35 million Boeing 737 sale to close late Q3 or early Q4.

$MNRMed

Mach Natural Resources (MNR) Q2 2026 Earnings Call Transcript

Mach Natural Resources LP (MNR) reported Q2 2026 revenue of $406 million and net income of $98 million, or $1.01 per common unit. Adjusted EBITDA was $182 million and operating cash flow $154 million. Production averaged 148.9k boe/d, with oil at 22.7k bpd and gas at 613 MMcf/d. The company declared a $0.36 distribution and projected reducing leverage from 1.4x to 1.0x by end-2027.

$RGAMed

RGA (RGA) Q2 2026 Earnings Call Transcript

Reinsurance Group of America (RGA) reported Q2 2026 adjusted operating income of $8.89 per diluted share, up from $4.72 a year earlier, citing strong investment returns and claims experience. Net premiums were $4.47 billion, up 7.7% YoY. The company said new money rate was 6.02% and excess capital was $2.2 billion, with $111 million returned via buybacks and dividends.

AEye (LIDR) Q2 2026 Earnings Call Transcript — alphai